Operating profit before deduction of amortization: SAB Biotherapeutics, Inc. (SABS)
The success of SAB Biotherapeutics (SABS) is based on strict cost control of biolabs and the availability of a financial reserve. The innovative brand creates human antibodies to combat viral pathologies, while the GURU.Markets terminal displays a chart of operating cash flow volume, where the current level is around 0.00. The issuer's future relies on platform validation and the results of type 1 diabetes therapy tests.
SAB Biotherapeutics, Inc. (SABS) - metric breakdowns and financial figures
- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
- shareholders' equity book value data:
- debt level and financial liquidity data:
Debt to Equity Ratio SAB Biotherapeutics|SABS - Long-Term Debt to Capital|Current Liabilities to Capital SAB Biotherapeutics Inc.|SABS - Company Debts|Debts to Net Assets SAB Biotherapeutics|SABS - Company Long-Term Debts|Company Short-Term Debts SAB Biotherapeutics|Quick Liquidity sabbiotherapeutics.com
- earnings and multiples data:
SABS - Net Income|Expected Net Income SAB Biotherapeutics|SABS - P/E Multiple|Future Price to Earnings sabbiotherapeutics.com|SABS - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio SAB Biotherapeutics|SABS - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months SAB Biotherapeutics|SABS - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months sabbiotherapeutics.com|SABS - Earnings growth in current year|Expected earnings per share trend next year SAB Biotherapeutics
Analysis of all company metrics:SABS SAB Biotherapeutics Inc
This indicator captures the net cash flow from core operations before debt service and taxes, allowing for an assessment of the business's fundamental viability excluding financial leverage. By analyzing the trend of operating profit before interest and taxes, an investor can weigh the current R&D expenditures of SAB Biotherapeutics (SABS) against the monetization potential of immunotherapy drugs within the growing autoimmune pathology treatment market.
Who SAB Biotherapeutics competes with
Operating income before deduction of amortization argenx BVBA (ARGX)|BNTX - Profit before payment of interest, taxes and amortization|Abivax S.A. (ABVX) - Operating profit before deduction of amortization|ADMA Biologics, Inc. (ADMA) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Protagonist Therapeutics, Inc.|Operating profit before deduction of amortization IMVT|Operating profit EBITDA Kiniksa Corp|Profit before payment of interest, taxes and amortization Grifols, S.A. (GRFS)|adaptivebiotech.com - Operating profit before amortization|Operating profit EBITDA CLDX (Celldex Therapeutics, Inc.)|Aurinia Pharmaceuticals Inc (AUPH) - Profit before interest, taxes and amortization|BCRX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Vera Corp VERA|DNTH: Operating profit EBITDA|pharvaris.com (PHVS) - Operating profit EBITDA|ABCL (AbCellera Biologics Inc.) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization TRML|Operating profit before deduction of amortization PGEN (Intrexon)|PHAR (Pharming Corp) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA NKTR (Nektar Therapeutics)|upstreambio.com - Profit before payment of interest, taxes and amortization|Zenas Biopharma - Operating profit EBITDA|Operating income before deduction of amortization Immunome Inc IMNM|Gossamer Corp (GOSS) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization KalVista Corp (KALV)|Operating profit before deduction of amortization SEPN|PVLA (pieris.com) - Company profit before taxes, interest and amortization|Operating profit EBITDA SVRA|RIGL (Rigel Pharma) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA ANAB (AnaptysBio Corp)|Astria Corp (ATXS) - Profit before interest, taxes and amortization|ENGN - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RAPT (RAPT Therapeutics Inc.)|JBIO: Operating profit EBITDA|Aclaris Therapeutics Inc. (ACRS) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Kyverna|Tiziana Life Sciences, Ltd. - Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA CABA|VTYX - Profit before interest, taxes and amortization|Theratechnologies - Operating profit before deduction of amortization|Operating profit EBITDA Avalo Therapeutics, Inc. AVTX|ELDN: Operating profit before deduction of amortization|Agenus, Inc - Company profit before taxes, interest and amortization|CLYM: Operating profit EBITDA|ZURA - Operating income before deduction of amortization|ATYR (aTyr Pharma) - Operating profit EBITDA|Operating profit before deduction of amortization Adagene Corp (ADAG)|Profit before payment of interest, taxes and amortization ImageneBio Inc (IMA)|Operating income before deduction of amortization shattucklabs.com|Profit before payment of interest, taxes and amortization Equillium EQ|Operating income before deduction of amortization Connect Biopharma Holdings (CNTB)|Immunic Inc - Operating profit EBITDA|ATRA - Operating profit EBITDA|IFRX: Operating profit EBITDA|XFOR (X4 Pharmaceuticals, Inc) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Adicet Bio Inc.|Celularity Corp (CELU) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization INmune Bio (INMB)|BRNS: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA KZR (Kezar Life Sciences, Inc)|Income before deduction of interest, taxes and amortization AKTX|Enlivex Therapeutics, Ltd. - Operating profit EBITDA|QTTB - Operating profit EBITDA|GeoVax (GOVX) - Profit before payment of interest, taxes and amortization|Edesa Biotech Inc - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization iBio Corp|Operating profit before deduction of amortization Carisma Tx (CARM)|Operating profit EBITDA XTLB|Operating profit EBITDA boltbio.com (BOLT)|HCW Biologics - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization APVO|AIM ImmunoTech Inc. - Operating profit EBITDA|Operating income before deduction of amortization Aditxt ADTX|GRI Bio, Inc. (GRI) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization xortx.com|Profit before payment of interest, taxes and amortization Vyome Holdings|Operating profit before deduction of amortization Revelation Biosciences Inc (REVB)|Operating profit before deduction of amortization INDP (Indaptus)|Operating profit EBITDA BiondVax Pharmaceuticals (SCNI)|Profit before payment of interest, taxes and amortization CalciMedica CALI|AFMD: Operating profit before amortization|Allakos Therapeutics - Operating profit EBITDA|Profit before interest, taxes and amortization HOOKIPA Pharma Inc.|igmbio.com (IGMS) - Profit before payment of interest, taxes and amortization|ITOS - Operating income before deduction of amortization|OCEA (Ocean Biomedical, Inc.) - Operating profit EBITDA|Operating profit EBITDA tcbiopharm.com|Operating profit EBITDA THRD
